Scott M Rocklage's Net Worth

$206 Million

Who is Scott M Rocklage?

Scott M Rocklage has an estimated net worth of $206 Million. This is based on reported shares across multiple companies, which include Skye Bioscience, Inc., Relypsa Inc, Crinetics Pharmaceuticals, Inc., Entrada Therapeutics, Inc., Pear Therapeutics, Inc., Pulmatrix, Inc., IDEAYA Biosciences, Inc., Rallybio Corp, ARVINAS, INC., IMPEL NEUROPHARMA INC, Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., EPIRUS Biopharmaceuticals, Inc., PHASERX, INC., CUBIST PHARMACEUTICALS INC, and Achaogen Inc.

SEC CIK

Scott M Rocklage's CIK is 0001219014

Past Insider Trading and Trends

2013 was Scott M Rocklage's most active year for acquiring shares with 36 total transactions. Scott M Rocklage's most active month to acquire stocks was the month of October. 2004 was Scott M Rocklage's most active year for disposing of shares, totalling 57 transactions. Scott M Rocklage's most active month to dispose stocks was the month of October. 2024 saw Scott M Rocklage paying a total of $12,026,030.94 for 5,206,074 shares, this is the most they've acquired in one year. In 2019 Scott M Rocklage cashed out on 13,292,745 shares for a total of $54,804,484.83, their largest year based on trade value.